SBV Journal of Basic, Clinical and Applied Health Science

Register      Login

VOLUME 3 , ISSUE 2 ( April-June, 2020 ) > List of Articles


COVID-19 in Siddha Medicine: A Review

JV Sabarianandh, Lazer Bernaitis, Kumarappan Manimekalai

Citation Information : Sabarianandh J, Bernaitis L, Manimekalai K. COVID-19 in Siddha Medicine: A Review. 2020; 3 (2):83-86.

DOI: 10.5005/jp-journals-10082-02256

License: CC BY-NC 4.0

Published Online: 09-10-2020

Copyright Statement:  Copyright © 2020; The Author(s).


“Severe acute respiratory syndrome coronavirus-2” is responsible for the COVID-19. It was identified in China in December 2019 and it was “declared as a pandemic” disease by “the World Health Organization” in “March 2020”. This review article is an attempt to give an insight into the management of COVID-19 in the Siddha medicine aspect to potential treatment strategies in herbal and herbomineral formulations for the recently recognized “SARS-CoV-2” L strain.

  1. Kahn J, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005;24(11 Suppl):S223–S227. DOI: 10.1097/01.inf.0000188166.17324.60.
  2. Goldsmith C, Tatti K, Ksiaze K, Rollin PE, Comer JA, Lee WW, et al. Ultra structural characterization of SARS coronavirus. Emerg Infect Dis 2004;10(13):320–326. DOI: 10.3201/eid1002.030913.
  3. Woo P, Wang M, Lau S, Xu H, Poon R, Guo R, et al. Comparative analysis of twelve genomes of three novel group 2C and group 2D coronaviruses reveals unique group and subgroup features. J Virol 2007;81(4):1574–1585. DOI: 10.1128/JVI.02182-06.
  4. Lau S, Woo P, Yip C, Fan R, Huang Y, Wang M, et al. Isolation and characterization of a novel beta coronavirus subgroup A coronavirus, rabbit coronavirus HKU14 from domestic rabbits. J Virol 2012;86(10):5481–5496. DOI: 10.1128/JVI.06927-11.
  5. Lau S, Poon R, Wong B, Wang M, Huang Y, Xu H, et al. Co-existence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel beta coronavirus subgroup. J Virol 2010;84(21):11385–11394. DOI: 10.1128/JVI.01121-10.
  6. Valencia DN. Brief review on COVID-19: the 2020 pandemic caused by SARS-CoV-2. Cureus 2020;12(3):e7386. DOI: 10.7759/cureus.7386.
  7. Coronavirus disease (COVID) Pandemic. (2020) Accessed: March 20, 2020:
  8. Coronavirus disease 2019 (COVID-19): situation summary(2020): http://www/
  9. Zumla A, Chan J, Azhar E, Hui D, Yuen K. Corona viruses-drug discovery and therapeutic options. Nat Rev Drug Discov 2016;15(5):327–347. DOI: 10.1038/nrd.2015.37.
  11. Kumar PM, Sundaram MK, Ramasamy MS. Coronavirus spike (s) glycoprotein (2019 N CoV) targeted Siddha medicines kabasura kudineer and Thonthasura kudineer-in silico evidence for corona viral drug. Asian J Pharm Res Health Care 2019;11(2):1–9.
  12. Dudani T, Saraogi A. Use of herbal medicines on coronavirus. Acta Sci Pharm Sci 2020;4(4):61–63. DOI: 10.31080/ASPS.2020.04.0518.
  13. Thas JJ. Siddha medicine background and principles and the application for skin diseases. Clin Dermatol 2008;26(1):62–78. DOI: 10.1016/j.clindermatol.2007.11.010.
  14. Murgesa Muthaliar Gundapadam-Thathu Jeevam Vaguppu (siddha Materia Medica) 1996.
  15. Ministry of AYUSH, Government of India. D.O.No.S.16030/18/2019—Nam 6th March 2020.
  16. Kuppusamy Muthaliyar. Sitha. Vaithiya Thirattu. Dept. of Indian Medicine and Homoeopathy, Chennai, 2009.
  17. Singh SK, Patel JR, Dangi A, Bachle D, Kataria RK. A complete over review on Adhatoda vasica a traditional medicinal plants. J Med Plants Stud 2017;5(1):175–180.
  18. Thillaivannan S, Parthiban P, Kanakavalli K, Sathiyarajeshwaran P. A review on kapa sura kudineer—A Siddha formulary prediction for swine flu. Int J Pharm Sci Drug Res 2015;7(5):376–383.
  19. Anonymous, Indian Pharmacopoeia Vol. II. Ministry of Health and Family welfare, Govt of India, New Delhi.
  20. Grzanna R, Lindmark L, Fronodoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005;8(2):125–132. DOI: 10.1089/jmf.2005.8.125.
  21. Dhuley JN. Antitussive effect of Adhatoda vasica extract on mechanical (or) chemical stimulation induced coughing in animals. J Ethnopharmacology 1999;67(3):361–365. DOI: 10.1016/S0378-8741(99)00074-4.
  22. Castillo AL, Ramos JDA, de Francia JL, Quilala PF, Dujunco MU. Immunomodulatory effects of Tinospora cordifolia lotion on interleukin-1, interleukin-6 and interleukin-8 levels in scabies-infected pediatric patients: A single blind, Randomized trial. Int J Pharm Sci Drug Res 2014;6(3):204–210.
  23. Methews S, Kuttan G. Antioxidant activities of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res 1997;16(4):407.
  24. Chen JX, Xue HJ, Ye WC, Fang BH, Liu YH, Yuan SH, et al. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol Pharm Bull 2009;32(8):1385–1391. DOI: 10.1248/bpb.32.1385.
  25. Balaramaya V. Sitha Maruthu Sei Muraigal. Chennai: Aruljothi Publishers; 1981;1:14.
  26. Saravana SP, Sivanantha A, Sasivel S, Siva Kumar G, Shanmugam M. Scientific analysis of vajra kandi chenduram a Siddha formulation towards its safety, pharmacological action and proposed benefits in the management of COVID-19. World J Pharm Res 2020;9(5): 2212–2226.
  27. Mohana Raj T. Pittam, peenisam mattrum sura noi thoguthi. 1st ed., A.T.S.V.S Siddha Medical college and Hospital; 2008. p. 254.
  28. Shailaja R, Sugunthan S, Pitchiah Kumar M. A review on polyherbal formulation-visha sura kudineer chooranam: A classical anti-viral drug used in siddha system of medicine. European J Pharm Med Res 2017;4(9):184–192.
  29. Rubeena M, Divya KG, Sunil KKN, Parameswaran S. Bio active molecules in siddha polyherbal nilavembu kudineer alleviating symptoms of dengu/chikugunya. Tradit Med Res 2018;3(5): 215–229.
  30. Kumar A, Ram J, Samarth RM, Kumar M. Modulatory influence of Adhatoda vasica Nees leaf extract against gamma irradiation in swiss albino mice. Phytomedicine 2005;12(4):285–293. DOI: 10.1016/j.phymed.2003.12.006.
  31. Tanaka T, Narazaki M, Kishimotol T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 2016;8(8): 959–970. DOI: 10.2217/imt-2016-0020.
  32. Ito M, Nakashima H, Baba M, Pauwels R, De Clercq E, Shigeta S, et al. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus. Antiviral Res 1987;7(3):127–137. DOI: 10.1016/0166-3542(87)90001-5.
  33. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavarin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 2003;58(1):73–79. DOI: 10.1016/S0166-3542(02)00185-7.
  34. Bharathajothi P, Bhaaskaran CT. Phytochemical and pharmacological evaluations of Aristolochia bracteolata lam. Asian J Plant Sci Res 2014;4(6):15–19.
  35. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing; 2020.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.